Li et al. [128] reported that the YY1/HDAC2 complex in ccRCC inhibited the expression of YTHDC1, thereby affecting the expression of its downstream target gene ANXA1 and inhibiting the sensitivity of ccRCC to tyrosinase inhibitors. Here, TYR is linked to nonpapillary renal cell carcinoma.